| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Malaria | 9 | 2011 | 1240 | 0.940 |
Why?
|
| Plasmodium chabaudi | 7 | 2011 | 19 | 0.880 |
Why?
|
| Anemia | 7 | 2006 | 1521 | 0.620 |
Why?
|
| Erythropoiesis | 3 | 2006 | 694 | 0.550 |
Why?
|
| HSP70 Heat-Shock Proteins | 12 | 2013 | 395 | 0.530 |
Why?
|
| Hodgkin Disease | 11 | 2017 | 1386 | 0.520 |
Why?
|
| Erythropoietin | 7 | 2006 | 719 | 0.500 |
Why?
|
| Erythrocytes | 4 | 2006 | 2422 | 0.400 |
Why?
|
| Heat-Shock Proteins | 10 | 2011 | 798 | 0.380 |
Why?
|
| Reticulocytosis | 3 | 2006 | 10 | 0.360 |
Why?
|
| Fiducial Markers | 1 | 2012 | 134 | 0.360 |
Why?
|
| Hot Temperature | 16 | 2004 | 1439 | 0.340 |
Why?
|
| Radiation-Sensitizing Agents | 5 | 2005 | 350 | 0.320 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2012 | 367 | 0.310 |
Why?
|
| Interleukin-12 | 3 | 2006 | 578 | 0.260 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2006 | 706 | 0.240 |
Why?
|
| Radiosurgery | 2 | 2012 | 1354 | 0.240 |
Why?
|
| Interleukin-2 | 1 | 2011 | 1894 | 0.230 |
Why?
|
| Ribosomal Protein S6 Kinases | 3 | 2004 | 203 | 0.220 |
Why?
|
| Antigens, Protozoan | 1 | 2006 | 316 | 0.220 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 1625 | 0.220 |
Why?
|
| Erythroid Precursor Cells | 1 | 2004 | 212 | 0.210 |
Why?
|
| Spleen | 7 | 2011 | 2298 | 0.210 |
Why?
|
| Radiation Oncology | 3 | 2007 | 573 | 0.200 |
Why?
|
| Cell Division | 4 | 2007 | 4479 | 0.200 |
Why?
|
| Biological Assay | 3 | 2002 | 629 | 0.200 |
Why?
|
| Interferon-gamma | 2 | 2011 | 3169 | 0.200 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2011 | 3816 | 0.200 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2002 | 306 | 0.180 |
Why?
|
| Antibodies, Protozoan | 1 | 2002 | 253 | 0.180 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2011 | 4419 | 0.180 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 4 | 2000 | 492 | 0.180 |
Why?
|
| Flow Cytometry | 3 | 2011 | 5904 | 0.170 |
Why?
|
| Antigen Presentation | 1 | 2006 | 1251 | 0.170 |
Why?
|
| Gap Junctions | 2 | 2001 | 230 | 0.170 |
Why?
|
| Salicylic Acid | 1 | 1999 | 62 | 0.170 |
Why?
|
| NF-kappa B | 6 | 2010 | 2491 | 0.160 |
Why?
|
| Etanidazole | 2 | 1996 | 22 | 0.160 |
Why?
|
| Neoplasms, Second Primary | 4 | 2014 | 1062 | 0.160 |
Why?
|
| Transcription, Genetic | 10 | 2011 | 7599 | 0.150 |
Why?
|
| Mice | 37 | 2018 | 82045 | 0.150 |
Why?
|
| Heat-Shock Response | 4 | 2011 | 179 | 0.150 |
Why?
|
| Chaperonins | 2 | 2008 | 58 | 0.150 |
Why?
|
| DNA-Binding Proteins | 14 | 2005 | 9623 | 0.150 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2018 | 123 | 0.140 |
Why?
|
| Injury Severity Score | 1 | 2001 | 1053 | 0.140 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 3108 | 0.140 |
Why?
|
| Antigens, Ly | 1 | 2018 | 296 | 0.140 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1999 | 501 | 0.140 |
Why?
|
| Cytokines | 7 | 2010 | 7449 | 0.140 |
Why?
|
| Buthionine Sulfoximine | 1 | 1996 | 17 | 0.140 |
Why?
|
| Interleukin-10 | 3 | 2011 | 1185 | 0.140 |
Why?
|
| Animals | 55 | 2018 | 169418 | 0.140 |
Why?
|
| Type C Phospholipases | 2 | 1993 | 287 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 10 | 2018 | 22365 | 0.130 |
Why?
|
| Radiobiology | 1 | 1996 | 91 | 0.130 |
Why?
|
| Phospholipases A | 2 | 1993 | 204 | 0.120 |
Why?
|
| Cricetinae | 16 | 2009 | 2423 | 0.120 |
Why?
|
| Kidney | 4 | 2005 | 7064 | 0.120 |
Why?
|
| Cancer Vaccines | 2 | 2013 | 1044 | 0.120 |
Why?
|
| Dendritic Cells | 1 | 2006 | 2757 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2022 | 8635 | 0.120 |
Why?
|
| Blue Cross Blue Shield Insurance Plans | 1 | 2014 | 92 | 0.110 |
Why?
|
| Neurofilament Proteins | 1 | 1996 | 337 | 0.110 |
Why?
|
| Calcium | 9 | 2009 | 5793 | 0.110 |
Why?
|
| Coculture Techniques | 3 | 2006 | 1343 | 0.110 |
Why?
|
| Reactive Oxygen Species | 2 | 2009 | 2150 | 0.110 |
Why?
|
| Mice, Inbred A | 2 | 2004 | 245 | 0.110 |
Why?
|
| Radiotherapy, Conformal | 2 | 2009 | 549 | 0.110 |
Why?
|
| Receptor, Insulin | 1 | 2016 | 838 | 0.100 |
Why?
|
| Recombinant Proteins | 4 | 2006 | 6527 | 0.100 |
Why?
|
| Injections, Intravenous | 2 | 2006 | 1379 | 0.100 |
Why?
|
| Molecular Chaperones | 4 | 2022 | 764 | 0.100 |
Why?
|
| Cell Survival | 9 | 2007 | 5801 | 0.100 |
Why?
|
| Cricetulus | 11 | 2009 | 815 | 0.100 |
Why?
|
| Cells | 1 | 1993 | 166 | 0.100 |
Why?
|
| Monocytes | 5 | 2002 | 2591 | 0.100 |
Why?
|
| HeLa Cells | 9 | 2011 | 3090 | 0.090 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2002 | 103 | 0.090 |
Why?
|
| Caspase 12 | 1 | 2010 | 8 | 0.090 |
Why?
|
| Enzyme Inhibitors | 3 | 2004 | 3734 | 0.090 |
Why?
|
| Immobilization | 1 | 2012 | 230 | 0.090 |
Why?
|
| Cell Line | 17 | 2007 | 15609 | 0.090 |
Why?
|
| Shock | 1 | 1993 | 316 | 0.090 |
Why?
|
| Epithelial Cells | 3 | 2005 | 3697 | 0.090 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2012 | 335 | 0.090 |
Why?
|
| ADAM Proteins | 2 | 2009 | 239 | 0.090 |
Why?
|
| Leukotriene B4 | 2 | 2001 | 281 | 0.090 |
Why?
|
| Misonidazole | 2 | 1989 | 33 | 0.090 |
Why?
|
| Hyperthermia, Induced | 3 | 2001 | 417 | 0.090 |
Why?
|
| Sugar Phosphates | 2 | 1987 | 44 | 0.090 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2009 | 1376 | 0.080 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2011 | 307 | 0.080 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2009 | 135 | 0.080 |
Why?
|
| Inositol Phosphates | 2 | 1987 | 175 | 0.080 |
Why?
|
| Neoplasms | 5 | 2014 | 22386 | 0.080 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2020 | 1755 | 0.080 |
Why?
|
| Fibroblasts | 7 | 2005 | 4180 | 0.080 |
Why?
|
| Arachidonic Acids | 1 | 1989 | 296 | 0.080 |
Why?
|
| Calmodulin | 1 | 1990 | 241 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 8 | 2005 | 6135 | 0.080 |
Why?
|
| Adenocarcinoma | 3 | 2020 | 6400 | 0.080 |
Why?
|
| Enzyme Activation | 5 | 2010 | 3594 | 0.080 |
Why?
|
| Interleukin-1 | 3 | 2002 | 1251 | 0.080 |
Why?
|
| Host-Parasite Interactions | 1 | 2011 | 302 | 0.080 |
Why?
|
| Lymphocyte Count | 1 | 2011 | 793 | 0.080 |
Why?
|
| Prostaglandins | 1 | 1989 | 398 | 0.080 |
Why?
|
| 3T3 Cells | 4 | 1999 | 1086 | 0.080 |
Why?
|
| Adoptive Transfer | 1 | 2011 | 825 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 9 | 2004 | 5803 | 0.080 |
Why?
|
| Nitroimidazoles | 1 | 1989 | 118 | 0.080 |
Why?
|
| Mammary Glands, Animal | 2 | 2001 | 273 | 0.070 |
Why?
|
| Wounds and Injuries | 1 | 2001 | 2518 | 0.070 |
Why?
|
| Spinal Cord | 1 | 1996 | 1814 | 0.070 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2014 | 811 | 0.070 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2001 | 507 | 0.070 |
Why?
|
| Aspirin | 1 | 1999 | 3139 | 0.070 |
Why?
|
| Radiotherapy | 2 | 2010 | 1510 | 0.070 |
Why?
|
| Quality of Life | 2 | 2009 | 13497 | 0.070 |
Why?
|
| Salivary Glands | 1 | 2009 | 231 | 0.070 |
Why?
|
| Mediastinal Neoplasms | 1 | 2010 | 403 | 0.070 |
Why?
|
| Autoantibodies | 1 | 2016 | 2131 | 0.070 |
Why?
|
| Pheochromocytoma | 1 | 1989 | 328 | 0.070 |
Why?
|
| Transfection | 10 | 2007 | 5767 | 0.070 |
Why?
|
| Thiamphenicol | 1 | 2006 | 2 | 0.070 |
Why?
|
| Ovary | 5 | 1987 | 960 | 0.070 |
Why?
|
| Mycobacterium bovis | 1 | 2007 | 148 | 0.070 |
Why?
|
| Cell Cycle Proteins | 2 | 2008 | 3463 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2022 | 3805 | 0.070 |
Why?
|
| Transcription Factors | 14 | 2011 | 12174 | 0.070 |
Why?
|
| Aleutian Mink Disease | 1 | 2005 | 1 | 0.070 |
Why?
|
| Cerebral Angiography | 1 | 2012 | 1282 | 0.070 |
Why?
|
| Injections, Intraperitoneal | 1 | 2006 | 413 | 0.070 |
Why?
|
| Salmonella Infections | 1 | 2007 | 172 | 0.060 |
Why?
|
| Interferon Regulatory Factors | 1 | 2007 | 268 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2016 | 4029 | 0.060 |
Why?
|
| Receptors, Cell Surface | 3 | 2005 | 2819 | 0.060 |
Why?
|
| Stress, Physiological | 2 | 2011 | 1409 | 0.060 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2007 | 180 | 0.060 |
Why?
|
| Phosphorylation | 9 | 2004 | 8332 | 0.060 |
Why?
|
| Respiratory Tract Neoplasms | 1 | 2005 | 56 | 0.060 |
Why?
|
| Apoptosis | 5 | 2007 | 9526 | 0.060 |
Why?
|
| Virus Shedding | 1 | 2005 | 110 | 0.060 |
Why?
|
| Ferrets | 1 | 2005 | 181 | 0.060 |
Why?
|
| Injections, Subcutaneous | 1 | 2006 | 681 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2004 | 474 | 0.060 |
Why?
|
| Phantoms, Imaging | 2 | 2012 | 2528 | 0.060 |
Why?
|
| Quercetin | 2 | 2004 | 96 | 0.060 |
Why?
|
| Neuregulin-1 | 1 | 2005 | 136 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 6 | 2007 | 6241 | 0.060 |
Why?
|
| Humans | 57 | 2022 | 768451 | 0.060 |
Why?
|
| Male | 32 | 2020 | 364781 | 0.060 |
Why?
|
| Prostatic Neoplasms | 5 | 2007 | 11206 | 0.060 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2005 | 166 | 0.060 |
Why?
|
| Genes, Reporter | 6 | 2007 | 1525 | 0.060 |
Why?
|
| Salmonella typhimurium | 2 | 2007 | 348 | 0.060 |
Why?
|
| Interleukin-6 | 4 | 2002 | 3234 | 0.060 |
Why?
|
| Gallium Radioisotopes | 1 | 2005 | 195 | 0.060 |
Why?
|
| Signal Transduction | 8 | 2010 | 23638 | 0.060 |
Why?
|
| Reproducibility of Results | 4 | 2020 | 20231 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2001 | 1246 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2004 | 4362 | 0.060 |
Why?
|
| Cell Membrane | 4 | 2007 | 3664 | 0.060 |
Why?
|
| Female | 36 | 2020 | 396943 | 0.060 |
Why?
|
| Radiation Injuries | 2 | 2009 | 1205 | 0.060 |
Why?
|
| Isoenzymes | 2 | 2018 | 1685 | 0.050 |
Why?
|
| Lymphocytes | 2 | 2009 | 2611 | 0.050 |
Why?
|
| Cell Line, Tumor | 7 | 2022 | 17149 | 0.050 |
Why?
|
| 14-3-3 Proteins | 1 | 2004 | 222 | 0.050 |
Why?
|
| Survivors | 1 | 2014 | 2381 | 0.050 |
Why?
|
| Neoplasm Staging | 8 | 2017 | 11249 | 0.050 |
Why?
|
| Electronic Health Records | 1 | 2020 | 4877 | 0.050 |
Why?
|
| Bleomycin | 3 | 2014 | 495 | 0.050 |
Why?
|
| Radiation Tolerance | 1 | 2005 | 478 | 0.050 |
Why?
|
| Untranslated Regions | 1 | 2022 | 30 | 0.050 |
Why?
|
| Lipopolysaccharides | 5 | 2002 | 2216 | 0.050 |
Why?
|
| Vinblastine | 3 | 2014 | 488 | 0.050 |
Why?
|
| Drosophila Proteins | 2 | 2002 | 1712 | 0.050 |
Why?
|
| Sphingosine | 1 | 2004 | 308 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 2018 | 7895 | 0.050 |
Why?
|
| Calcimycin | 3 | 2000 | 214 | 0.050 |
Why?
|
| Particle Accelerators | 1 | 2003 | 175 | 0.050 |
Why?
|
| Oncogenes | 1 | 2008 | 1235 | 0.050 |
Why?
|
| Metalloendopeptidases | 1 | 2004 | 389 | 0.050 |
Why?
|
| Receptors, Transferrin | 1 | 2004 | 300 | 0.050 |
Why?
|
| CHO Cells | 5 | 2009 | 1382 | 0.050 |
Why?
|
| Salmonella Infections, Animal | 1 | 2002 | 60 | 0.050 |
Why?
|
| Pyruvate Kinase | 1 | 2004 | 190 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2009 | 1254 | 0.050 |
Why?
|
| DNA | 2 | 1999 | 7213 | 0.050 |
Why?
|
| Sulindac | 1 | 2001 | 29 | 0.050 |
Why?
|
| Carrier State | 1 | 2005 | 529 | 0.050 |
Why?
|
| eIF-2 Kinase | 1 | 2002 | 147 | 0.050 |
Why?
|
| Immune Sera | 1 | 2002 | 605 | 0.050 |
Why?
|
| Protein Kinase C | 2 | 1998 | 1207 | 0.050 |
Why?
|
| Concanavalin A | 1 | 1981 | 190 | 0.050 |
Why?
|
| Respiration | 1 | 2008 | 1667 | 0.050 |
Why?
|
| Antigen-Presenting Cells | 1 | 2005 | 965 | 0.050 |
Why?
|
| Phospholipases A2 | 2 | 1993 | 197 | 0.050 |
Why?
|
| Transplantation Chimera | 1 | 2004 | 594 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2000 | 2279 | 0.050 |
Why?
|
| Lymphoma, Follicular | 1 | 2005 | 460 | 0.050 |
Why?
|
| Robotics | 1 | 2008 | 826 | 0.050 |
Why?
|
| Dacarbazine | 3 | 2014 | 560 | 0.050 |
Why?
|
| Mice, Inbred Strains | 1 | 2004 | 1770 | 0.050 |
Why?
|
| Movement | 1 | 2008 | 1489 | 0.050 |
Why?
|
| RNA, Double-Stranded | 1 | 2002 | 292 | 0.050 |
Why?
|
| Uridine | 1 | 2001 | 135 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2004 | 943 | 0.040 |
Why?
|
| Tritium | 1 | 2001 | 707 | 0.040 |
Why?
|
| Thyroid Neoplasms | 1 | 2014 | 2360 | 0.040 |
Why?
|
| Career Choice | 1 | 2007 | 769 | 0.040 |
Why?
|
| Antigens, Nuclear | 1 | 2001 | 184 | 0.040 |
Why?
|
| Breast | 1 | 2009 | 1976 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2004 | 1158 | 0.040 |
Why?
|
| Procarbazine | 2 | 2014 | 172 | 0.040 |
Why?
|
| Mechlorethamine | 2 | 2014 | 129 | 0.040 |
Why?
|
| Connexin 43 | 1 | 2001 | 202 | 0.040 |
Why?
|
| Ibuprofen | 1 | 2001 | 229 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2006 | 1531 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2008 | 13708 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 1977 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2014 | 11843 | 0.040 |
Why?
|
| Species Specificity | 1 | 2004 | 2422 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 2001 | 916 | 0.040 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2001 | 361 | 0.040 |
Why?
|
| Rats | 5 | 2001 | 23839 | 0.040 |
Why?
|
| Mitogens | 1 | 1999 | 229 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2002 | 621 | 0.040 |
Why?
|
| I-kappa B Proteins | 1 | 2000 | 210 | 0.040 |
Why?
|
| Interphase | 1 | 1999 | 227 | 0.040 |
Why?
|
| Teaching | 1 | 2007 | 1174 | 0.040 |
Why?
|
| Plasmids | 4 | 2007 | 2269 | 0.040 |
Why?
|
| Connexins | 1 | 2001 | 355 | 0.040 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2000 | 329 | 0.040 |
Why?
|
| Blood Transfusion | 1 | 2005 | 1308 | 0.040 |
Why?
|
| Lung | 5 | 2009 | 10090 | 0.040 |
Why?
|
| Cell Differentiation | 3 | 2006 | 11674 | 0.040 |
Why?
|
| Cell Movement | 2 | 2022 | 5223 | 0.040 |
Why?
|
| Retinal Dehydrogenase | 1 | 2018 | 78 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 9558 | 0.040 |
Why?
|
| Faculty, Medical | 1 | 2007 | 1218 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2006 | 2415 | 0.040 |
Why?
|
| Gene Expression Regulation | 6 | 2011 | 11930 | 0.040 |
Why?
|
| Pseudomonas Infections | 1 | 2002 | 623 | 0.040 |
Why?
|
| G1 Phase | 1 | 1999 | 404 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2006 | 1924 | 0.040 |
Why?
|
| Genes, fos | 1 | 1997 | 176 | 0.040 |
Why?
|
| Pneumonia | 1 | 2009 | 2162 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2010 | 2816 | 0.040 |
Why?
|
| Doxorubicin | 3 | 2014 | 2229 | 0.040 |
Why?
|
| Vincristine | 2 | 2014 | 1039 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 11138 | 0.040 |
Why?
|
| Cells, Cultured | 7 | 2005 | 19041 | 0.040 |
Why?
|
| DNA Damage | 2 | 2018 | 2461 | 0.030 |
Why?
|
| Phosphatidylinositols | 2 | 1988 | 280 | 0.030 |
Why?
|
| Lung Neoplasms | 3 | 2011 | 13589 | 0.030 |
Why?
|
| DEAE-Dextran | 2 | 1986 | 9 | 0.030 |
Why?
|
| NIH 3T3 Cells | 2 | 2011 | 669 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2002 | 2889 | 0.030 |
Why?
|
| Mitochondria | 1 | 2009 | 3672 | 0.030 |
Why?
|
| DNA Repair | 2 | 1996 | 2051 | 0.030 |
Why?
|
| Dogs | 1 | 2001 | 3847 | 0.030 |
Why?
|
| Thymus Gland | 1 | 2001 | 1267 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1999 | 1775 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2001 | 853 | 0.030 |
Why?
|
| Transcriptional Activation | 3 | 2009 | 1751 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2004 | 1602 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2007 | 3080 | 0.030 |
Why?
|
| Superoxides | 1 | 1996 | 389 | 0.030 |
Why?
|
| Prednisone | 2 | 2014 | 1568 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2011 | 5426 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1997 | 583 | 0.030 |
Why?
|
| Ethanol | 1 | 1981 | 1334 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 9066 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 5495 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2005 | 12813 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2002 | 1013 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2002 | 1277 | 0.030 |
Why?
|
| Middle Aged | 15 | 2017 | 223418 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2005 | 414 | 0.030 |
Why?
|
| Neoplasm Transplantation | 3 | 2005 | 2017 | 0.030 |
Why?
|
| Aged | 13 | 2017 | 171520 | 0.030 |
Why?
|
| Serine | 1 | 1998 | 831 | 0.030 |
Why?
|
| Combined Modality Therapy | 5 | 2005 | 8559 | 0.030 |
Why?
|
| Tuberculosis | 1 | 2007 | 2030 | 0.030 |
Why?
|
| Membrane Glycoproteins | 2 | 2002 | 3713 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2009 | 882 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2022 | 3637 | 0.030 |
Why?
|
| Mice, Knockout | 3 | 2010 | 14480 | 0.030 |
Why?
|
| Time Factors | 10 | 2009 | 40271 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 1996 | 796 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 9263 | 0.030 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 3 | 1993 | 110 | 0.030 |
Why?
|
| Dextrans | 2 | 1986 | 574 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2000 | 1608 | 0.030 |
Why?
|
| Adult | 14 | 2017 | 223542 | 0.030 |
Why?
|
| Stimulation, Chemical | 1 | 1993 | 306 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4586 | 0.030 |
Why?
|
| Adolescent | 9 | 2014 | 89168 | 0.030 |
Why?
|
| Aged, 80 and over | 8 | 2014 | 59680 | 0.030 |
Why?
|
| Protein Binding | 5 | 2004 | 9376 | 0.030 |
Why?
|
| Luciferases | 3 | 2000 | 712 | 0.030 |
Why?
|
| Carcinoma | 1 | 2005 | 2341 | 0.030 |
Why?
|
| Child, Preschool | 5 | 2014 | 42623 | 0.030 |
Why?
|
| Recurrence | 4 | 2007 | 8510 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1994 | 826 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2014 | 509 | 0.030 |
Why?
|
| Guanosine Triphosphate | 1 | 1993 | 315 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2002 | 2209 | 0.030 |
Why?
|
| Acetylcysteine | 1 | 1994 | 262 | 0.030 |
Why?
|
| Macrophages | 1 | 2007 | 5797 | 0.030 |
Why?
|
| Precipitin Tests | 2 | 2004 | 816 | 0.020 |
Why?
|
| Drug Synergism | 1 | 1996 | 1765 | 0.020 |
Why?
|
| Mice, Nude | 3 | 2005 | 3635 | 0.020 |
Why?
|
| Disease-Free Survival | 3 | 2009 | 6856 | 0.020 |
Why?
|
| Sodium Salicylate | 2 | 2002 | 18 | 0.020 |
Why?
|
| Cause of Death | 2 | 2017 | 3727 | 0.020 |
Why?
|
| Child | 8 | 2014 | 80863 | 0.020 |
Why?
|
| Protein Biosynthesis | 3 | 2004 | 2096 | 0.020 |
Why?
|
| Adenosine Triphosphate | 2 | 2009 | 2003 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2007 | 586 | 0.020 |
Why?
|
| Disease Progression | 3 | 2005 | 13655 | 0.020 |
Why?
|
| Glutathione Transferase | 2 | 2004 | 567 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 14158 | 0.020 |
Why?
|
| Blotting, Western | 3 | 2004 | 5042 | 0.020 |
Why?
|
| Temperature | 3 | 2004 | 2237 | 0.020 |
Why?
|
| Thrombin | 2 | 1993 | 600 | 0.020 |
Why?
|
| Age of Onset | 2 | 2010 | 3342 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1999 | 2450 | 0.020 |
Why?
|
| Inflammation | 1 | 2010 | 10865 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1996 | 2696 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 2007 | 17647 | 0.020 |
Why?
|
| Blood | 1 | 1993 | 597 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2012 | 20762 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 1994 | 742 | 0.020 |
Why?
|
| Amino Acid Substitution | 2 | 2007 | 1744 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2002 | 4572 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2002 | 348 | 0.020 |
Why?
|
| Neurons | 1 | 1989 | 9504 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1997 | 1766 | 0.020 |
Why?
|
| Bradykinin | 1 | 1989 | 205 | 0.020 |
Why?
|
| Amifostine | 1 | 2009 | 40 | 0.020 |
Why?
|
| Salivary Glands, Minor | 1 | 2009 | 27 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2014 | 888 | 0.020 |
Why?
|
| Submandibular Gland | 1 | 2009 | 85 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2009 | 364 | 0.020 |
Why?
|
| Mediastinum | 1 | 2010 | 273 | 0.020 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1990 | 205 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2009 | 21156 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 1993 | 947 | 0.020 |
Why?
|
| Radiation-Protective Agents | 1 | 2009 | 88 | 0.020 |
Why?
|
| Xerostomia | 1 | 2009 | 94 | 0.020 |
Why?
|
| Reimbursement Mechanisms | 1 | 2014 | 677 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2011 | 6537 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 2 | 2004 | 2072 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2009 | 151 | 0.020 |
Why?
|
| Intermediate Filaments | 1 | 1989 | 171 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1990 | 1144 | 0.020 |
Why?
|
| Salvage Therapy | 2 | 2006 | 1277 | 0.020 |
Why?
|
| Models, Biological | 3 | 2007 | 9505 | 0.020 |
Why?
|
| Toll-Like Receptors | 2 | 2002 | 582 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2004 | 18388 | 0.020 |
Why?
|
| beta-Galactosidase | 2 | 2000 | 575 | 0.020 |
Why?
|
| Parotid Gland | 1 | 2009 | 178 | 0.020 |
Why?
|
| Glycogen Synthase Kinases | 2 | 1998 | 40 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 7451 | 0.020 |
Why?
|
| RNA, Catalytic | 1 | 2007 | 52 | 0.020 |
Why?
|
| Eicosanoids | 1 | 1989 | 284 | 0.020 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2007 | 58 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 1994 | 2232 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2007 | 352 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 4931 | 0.020 |
Why?
|
| Massachusetts | 2 | 2014 | 8908 | 0.020 |
Why?
|
| Receptors, Concanavalin A | 1 | 1986 | 11 | 0.020 |
Why?
|
| Research | 1 | 1996 | 1984 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 1996 | 3550 | 0.020 |
Why?
|
| Exhalation | 1 | 2008 | 185 | 0.020 |
Why?
|
| Receptor Aggregation | 1 | 1986 | 72 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 1514 | 0.020 |
Why?
|
| Multiple Myeloma | 1 | 2005 | 5192 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2014 | 2925 | 0.020 |
Why?
|
| Health Services Research | 1 | 2014 | 1815 | 0.020 |
Why?
|
| Parasitemia | 1 | 2007 | 165 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 14728 | 0.020 |
Why?
|
| Multigene Family | 1 | 1990 | 1081 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2011 | 699 | 0.020 |
Why?
|
| Phosphatidic Acids | 1 | 1986 | 50 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2005 | 6242 | 0.020 |
Why?
|
| Abdominal Neoplasms | 1 | 2008 | 287 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2007 | 5952 | 0.020 |
Why?
|
| Down-Regulation | 1 | 1994 | 2944 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 2826 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2001 | 1688 | 0.020 |
Why?
|
| Oncogene Proteins v-erbB | 1 | 2005 | 17 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2001 | 5808 | 0.020 |
Why?
|
| Diglycerides | 1 | 1986 | 176 | 0.020 |
Why?
|
| Retrospective Studies | 5 | 2017 | 81834 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2005 | 116 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2007 | 574 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2009 | 660 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2004 | 13452 | 0.020 |
Why?
|
| Mathematics | 2 | 2003 | 704 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2005 | 5891 | 0.020 |
Why?
|
| Disease Susceptibility | 2 | 2002 | 1797 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2011 | 1575 | 0.020 |
Why?
|
| Sex Factors | 2 | 2014 | 10647 | 0.020 |
Why?
|
| DNA, Antisense | 1 | 2004 | 44 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2013 | 1357 | 0.020 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 2004 | 40 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2007 | 751 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1987 | 1734 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2007 | 423 | 0.010 |
Why?
|
| Methionine | 1 | 1987 | 574 | 0.010 |
Why?
|
| Cation Transport Proteins | 1 | 2007 | 326 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2007 | 625 | 0.010 |
Why?
|
| Research Design | 1 | 2020 | 6217 | 0.010 |
Why?
|
| Endosomes | 1 | 2007 | 526 | 0.010 |
Why?
|
| Career Mobility | 1 | 2007 | 262 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 2 | 2004 | 2640 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1990 | 1193 | 0.010 |
Why?
|
| Disintegrins | 1 | 2004 | 27 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 1985 | 423 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2004 | 240 | 0.010 |
Why?
|
| Cell-Free System | 1 | 2004 | 340 | 0.010 |
Why?
|
| Gold | 1 | 2008 | 489 | 0.010 |
Why?
|
| Binding Sites | 2 | 2004 | 6030 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 1755 | 0.010 |
Why?
|
| Saliva | 1 | 2009 | 854 | 0.010 |
Why?
|
| Urine | 1 | 2005 | 363 | 0.010 |
Why?
|
| Heart | 2 | 2010 | 4451 | 0.010 |
Why?
|
| Prognosis | 2 | 2004 | 30028 | 0.010 |
Why?
|
| Electrons | 1 | 2005 | 266 | 0.010 |
Why?
|
| Drug Discovery | 1 | 2011 | 1062 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 616 | 0.010 |
Why?
|
| Age Factors | 2 | 2014 | 18478 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2009 | 2656 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 2004 | 438 | 0.010 |
Why?
|
| Necrosis | 1 | 2007 | 1621 | 0.010 |
Why?
|
| Serpins | 1 | 2004 | 247 | 0.010 |
Why?
|
| Kinetics | 3 | 2004 | 6348 | 0.010 |
Why?
|
| Tattooing | 1 | 2003 | 57 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 478 | 0.010 |
Why?
|
| Carcinoma, Small Cell | 1 | 2005 | 420 | 0.010 |
Why?
|
| Genes, fms | 1 | 2002 | 6 | 0.010 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2007 | 687 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2004 | 506 | 0.010 |
Why?
|
| Lysosomes | 1 | 2007 | 934 | 0.010 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2002 | 94 | 0.010 |
Why?
|
| Immunologic Capping | 1 | 1981 | 30 | 0.010 |
Why?
|
| Deuterium Oxide | 1 | 1981 | 34 | 0.010 |
Why?
|
| Biological Transport | 1 | 1986 | 2089 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2002 | 293 | 0.010 |
Why?
|
| Mentors | 1 | 2007 | 672 | 0.010 |
Why?
|
| Scattering, Radiation | 1 | 2003 | 491 | 0.010 |
Why?
|
| Deuterium | 1 | 1981 | 106 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 699 | 0.010 |
Why?
|
| Prostheses and Implants | 1 | 2008 | 1279 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 839 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2014 | 3265 | 0.010 |
Why?
|
| Young Adult | 3 | 2014 | 60045 | 0.010 |
Why?
|
| Axons | 1 | 1989 | 1678 | 0.010 |
Why?
|
| Syndrome | 1 | 2007 | 3278 | 0.010 |
Why?
|
| Thapsigargin | 1 | 2000 | 102 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 2000 | 166 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1985 | 1468 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 1553 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 2009 | 1973 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 1992 | 0.010 |
Why?
|
| Atmospheric Pressure | 1 | 1980 | 48 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2000 | 3735 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2001 | 26395 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2005 | 1998 | 0.010 |
Why?
|
| Response Elements | 1 | 2002 | 308 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2002 | 518 | 0.010 |
Why?
|
| Follow-Up Studies | 3 | 2009 | 39430 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2002 | 762 | 0.010 |
Why?
|
| X-Rays | 1 | 1981 | 312 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2002 | 515 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 1989 | 2170 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2000 | 178 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2005 | 2286 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2004 | 1503 | 0.010 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2004 | 619 | 0.010 |
Why?
|
| Calcineurin | 1 | 2000 | 236 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2001 | 26351 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2009 | 54914 | 0.010 |
Why?
|
| Endotoxins | 1 | 2002 | 520 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1999 | 221 | 0.010 |
Why?
|
| Cell Proliferation | 2 | 2005 | 10494 | 0.010 |
Why?
|
| Age Distribution | 1 | 2005 | 2881 | 0.010 |
Why?
|
| K562 Cells | 1 | 2001 | 645 | 0.010 |
Why?
|
| Chelating Agents | 1 | 2000 | 385 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 911 | 0.010 |
Why?
|
| Lac Operon | 1 | 1999 | 237 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1999 | 190 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1999 | 343 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2004 | 1209 | 0.010 |
Why?
|
| Fluoroscopy | 1 | 2003 | 952 | 0.010 |
Why?
|
| Posture | 1 | 2003 | 956 | 0.010 |
Why?
|
| Desmosomes | 1 | 1998 | 73 | 0.010 |
Why?
|
| Mesothelioma | 1 | 2005 | 811 | 0.010 |
Why?
|
| Infant | 1 | 2001 | 36497 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2005 | 2206 | 0.010 |
Why?
|
| Treatment Outcome | 4 | 2006 | 65409 | 0.010 |
Why?
|
| Dinoprostone | 1 | 2001 | 597 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2014 | 24311 | 0.010 |
Why?
|
| Risk Factors | 3 | 2014 | 74915 | 0.010 |
Why?
|
| Survival Rate | 2 | 2002 | 12875 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2014 | 8081 | 0.010 |
Why?
|
| Protein Kinase C-alpha | 1 | 1998 | 113 | 0.010 |
Why?
|
| Liver | 2 | 2005 | 7575 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2007 | 2594 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2000 | 780 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2007 | 2048 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 5342 | 0.010 |
Why?
|
| Epitopes | 1 | 2004 | 2526 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2004 | 1803 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2004 | 1489 | 0.010 |
Why?
|
| United States | 2 | 2007 | 73121 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 3790 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 3281 | 0.010 |
Why?
|
| Radiography | 1 | 2008 | 6995 | 0.010 |
Why?
|
| Tacrolimus | 1 | 2000 | 750 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 1660 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 12428 | 0.010 |
Why?
|
| Heparin | 1 | 2004 | 1636 | 0.010 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1997 | 325 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1996 | 260 | 0.010 |
Why?
|
| Phosphoserine | 1 | 1996 | 204 | 0.010 |
Why?
|
| Prostate | 1 | 2005 | 1781 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 2393 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3794 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2004 | 2206 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2000 | 1170 | 0.010 |
Why?
|
| Tight Junctions | 1 | 1998 | 325 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 10784 | 0.010 |
Why?
|
| RNA Interference | 1 | 2004 | 2832 | 0.010 |
Why?
|
| Incidence | 2 | 2005 | 21552 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1999 | 1133 | 0.010 |
Why?
|
| Equipment Design | 1 | 2003 | 3530 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 1985 | 2901 | 0.010 |
Why?
|
| Mortality | 1 | 2005 | 2917 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2005 | 3212 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1993 | 154 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 1993 | 176 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2002 | 2146 | 0.010 |
Why?
|
| Peptides | 1 | 2005 | 4368 | 0.010 |
Why?
|
| RNA | 1 | 2002 | 2727 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2005 | 10125 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 1998 | 1615 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2005 | 3586 | 0.010 |
Why?
|
| Body Weight | 1 | 2002 | 4630 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1996 | 3073 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2002 | 2987 | 0.010 |
Why?
|
| Risk | 1 | 2002 | 9642 | 0.010 |
Why?
|
| Comorbidity | 1 | 2005 | 10601 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2007 | 6657 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 18048 | 0.000 |
Why?
|
| Aminoquinolines | 1 | 1988 | 105 | 0.000 |
Why?
|
| Immunosuppressive Agents | 1 | 2000 | 4213 | 0.000 |
Why?
|
| Methylglucosides | 1 | 1986 | 35 | 0.000 |
Why?
|
| 3-O-Methylglucose | 1 | 1986 | 37 | 0.000 |
Why?
|
| Rubidium | 1 | 1986 | 121 | 0.000 |
Why?
|
| Indicators and Reagents | 1 | 1988 | 455 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 15965 | 0.000 |
Why?
|
| Surface-Active Agents | 1 | 1986 | 152 | 0.000 |
Why?
|
| Gene Expression | 1 | 1999 | 7605 | 0.000 |
Why?
|
| Inositol | 1 | 1987 | 216 | 0.000 |
Why?
|
| Membrane Lipids | 1 | 1987 | 251 | 0.000 |
Why?
|
| Bucladesine | 1 | 1985 | 118 | 0.000 |
Why?
|
| Deoxyglucose | 1 | 1985 | 333 | 0.000 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2000 | 5709 | 0.000 |
Why?
|
| Adenosine Monophosphate | 1 | 1985 | 233 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1985 | 1310 | 0.000 |
Why?
|
| Dextran Sulfate | 1 | 1984 | 258 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2005 | 41797 | 0.000 |
Why?
|
| Membrane Fluidity | 1 | 1980 | 67 | 0.000 |
Why?
|
| Drug Resistance | 1 | 1985 | 1599 | 0.000 |
Why?
|